Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01604603
Other study ID # WFH-TMU-RetroMcLab-201203022
Secondary ID
Status Completed
Phase N/A
First received May 21, 2012
Last updated November 4, 2013
Start date April 2012
Est. completion date April 2013

Study information

Verified date November 2013
Source Taipei Medical University WanFang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: Menstrual disturbance is the major complain in reproductive age women, the clinical and biochemical characteristics of women with different menstrual disturbance had not been well-understood. Objective: To study the clinical and biochemical characteristics of women with oligomenorrhea, amenorrhea, and premature ovarian failure. Method: Retrospective study, medical records reviewed in patients who visited to outpatient clinic of Reproductive Medicine in Taipei Medical University - Wan Fang Hospital form 2009 Jan. 1 to 2011 Nov. 31. Including criteria: Patients had sufficient medical records (anthropometric, endocrine, metabolic, lipid parameters) and age less than 45. Excluding criteria: (1) Women who experienced menarche <3 years before the beginning of the study; (2) Women who received hormones or drugs for major medical diseases; (3) Women who presented ovarian cysts or ovarian tumors, uterine abnormality; (4) Women who were >45 years old.


Recruitment information / eligibility

Status Completed
Enrollment 470
Est. completion date April 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Female
Age group 13 Years to 45 Years
Eligibility Inclusion Criteria:

- Patients had sufficient medical records (anthropometric, endocrine, metabolic, lipid parameters) and age less than 45.

Exclusion Criteria:

1. Women who experienced menarche <3 years before the beginning of the study;

2. Women who received hormones or drugs for major medical diseases;

3. Women who presented ovarian cysts or ovarian tumors, uterine abnormality;

4. Women who were >45 years old.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan WanFang Medical Center at Taipei Medical University Taipei City

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan, 

See also
  Status Clinical Trial Phase
Completed NCT02029144 - Observational Study of Dydrogesterone in Cycle Regularization N/A
Completed NCT01711216 - Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan N/A
Completed NCT01525563 - Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study N/A